IJMDC

Article Text
Article Info
Citation Tools
Article Metrics
Permissions

Original Article

IJMDC. 2023; 7(6): 874-879

Comparing unfractionated heparin dose for VTE in obese versus non-obese patients

Authors: Sara A. Alsayed, Christopher D. Lyman.

ABSTRACT

Background: Venous thromboembolism (VTE) is treated based on body weight to determine unfractionated heparin (UFH) dosage. However, this approach has not been thoroughly studied in obese patients. We aimed to determine the optimal infusion rate of UFH in obese patients using the weight-based dosing nomogram. Methods: A retrospective review was conducted on adult patients treated with heparin per VTE protocol with activated thromboplastin time (aPTT) of 60-80 seconds. We calculated the median heparin infusion rate (units/kg/hour) required to achieve the first therapeutic aPTT in obese and non-obese patients. We also investigated the median time required to achieve the first therapeutic aPTT in both groups, the percentage of aPTT at the target goal within the first 24 hours of treatment, the percentage of sub and supra-therapeutic aPTT at 24 hours after initiation of heparin infusion, and incidence of thrombosis and bleeding during heparin treatment. Results: We included 70 patients with confirmed VTE diagnosis. Obese patients required a lower UFH infusion rate (units/kg/hour) compared to non-obese patients (16.5 vs. 18, p = 0.24). The time to reach the first therapeutic aPTT was longer in obese patients compared to non-obese (17.7 hours vs. 15 hours respectively, p = 0.7). Major bleeding events were higher in the obese patients compared to the non-obese (6.25% vs. 2.6%, p = 0.44). In contrast, minor bleeding events were higher in the non-obese group (28.1% vs. 36.8%, p = 0.46). The overall rate of thrombotic events occurring during heparin treatment was 6.2% in obese patients and 5.3% in non-obese patients (p = 0.86). Conclusion: Dosing of UFH in obese patients using the weight-based nomogram was associated with over-anticoagulation and demonstrated no significant difference in UFH dosing to reach the goal of aPTT in obese or non-obese patients.

Keywords:
Venous thromboembolism, unfractionated heparin, obesity, retrospective

View PDF

Comparing unfractionated heparin dose for VTE in obese versus non-obese patients

Authors
Sara A Alsayed
Department of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia
PubMed articles Google scholar articles

Christopher D Lyman
Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
PubMed articles Google scholar articles

Correspondence to:
. Sara A Alsayed, Department of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia; salsayed@windowslive.com

Publication history
Received 04 Jan 2023
Accepted 17 Jan 2023
Published online 13 Feb 2023
Published in print 13 Mar 2023

How to cite this article?

Export to EndNote Export to refMan

Pubmed Style

Alsayed SA, Lyman CD. Comparing unfractionated heparin dose for VTE in obese versus non-obese patients. IJMDC. 2023; 7(6): 874-879. doi:10.24911/IJMDC.51-1672875664

Web Style

Alsayed SA, Lyman CD. Comparing unfractionated heparin dose for VTE in obese versus non-obese patients. https://www.ijmdc.com/?mno=136575 [Access: May 28, 2023]. doi:10.24911/IJMDC.51-1672875664

AMA (American Medical Association) Style

Alsayed SA, Lyman CD. Comparing unfractionated heparin dose for VTE in obese versus non-obese patients. IJMDC. 2023; 7(6): 874-879. doi:10.24911/IJMDC.51-1672875664

Vancouver/ICMJE Style

Alsayed SA, Lyman CD. Comparing unfractionated heparin dose for VTE in obese versus non-obese patients. IJMDC. (2023), [cited May 28, 2023]; 7(6): 874-879. doi:10.24911/IJMDC.51-1672875664

Harvard Style

Alsayed, S. A. & Lyman, . C. D. (2023) Comparing unfractionated heparin dose for VTE in obese versus non-obese patients. IJMDC, 7 (6), 874-879. doi:10.24911/IJMDC.51-1672875664

Turabian Style

Alsayed, Sara A., and Christopher D. Lyman. 2023. Comparing unfractionated heparin dose for VTE in obese versus non-obese patients. International Journal of Medicine in Developing Countries, 7 (6), 874-879. doi:10.24911/IJMDC.51-1672875664

Chicago Style

Alsayed, Sara A., and Christopher D. Lyman. "Comparing unfractionated heparin dose for VTE in obese versus non-obese patients." International Journal of Medicine in Developing Countries 7 (2023), 874-879. doi:10.24911/IJMDC.51-1672875664

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Alsayed, S. A. & Lyman, . C. D. (2023) Comparing unfractionated heparin dose for VTE in obese versus non-obese patients. International Journal of Medicine in Developing Countries, 7 (6), 874-879. doi:10.24911/IJMDC.51-1672875664

Article Statistics

Request permissions

If you wish to reuse any part or all of this article please contact the copyright holder, contact@ijmdc.com.

International Journal of Medicine in Developing Countries